— Know what they know.
Not Investment Advice

SVRA NASDAQ

Savara Inc.
1W: -4.0% 1M: -1.6% 3M: -8.5% YTD: -10.3% 1Y: +61.1% 3Y: +134.3% 5Y: +224.4%
$5.02
-0.04 (-0.79%)
 
Weekly Expected Move ±7.6%
$4 $5 $5 $5 $6
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 33 · $1.0B mcap · 106M float · 1.46% daily turnover · Short 73% of daily vol

Cash Flow Trends

Operating Cash Flow
-$101M -13.4% ▼
Capital Expenditures
$22K +12.0% ▲
5Y CAGR: -63.3%
Free Cash Flow
-$101M -13.4% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$5M -416.6% ▼
Net Change in Cash
$18M +257.6% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$43M-$38M-$55M-$96M-$119M
Depreciation & Amort.$367K$167K$77K$130K$87K
Stock-Based Comp.$3M$2M$4M$10M$14M
Change in Working Capital-$3M$960K$4M$2M$5M
Other Non-Cash Items$449K$428K-$5M-$5M-$2M
Operating Cash Flow-$40M-$35M-$51M-$89M-$101M
— Investing Activities —
Capital Expenditures-$57K-$9K-$296K-$25K-$22K
Acquisitions (Net)-$8M$0$57K$0$0
Investment Purchases-$161M-$89M-$194M-$205M-$205M
Investment Sales$92M$142M$137M$165M$182M
Other Investing$8M$0-$57K$0$4M
Investing Cash Flow-$69M$53M-$57M-$40M-$18M
— Financing Activities —
Net Debt Issuance$0$88K$0$0$2M
Stock Repurchased-$78K-$3K-$1M-$995K-$5M
Dividends Paid$0$0$0$0$0
Other Financing-$1M$2K$0$400K$0
Financing Cash Flow$121M$87K$83M$118M$138M
Net Change in Cash$11M$18M-$26M-$11M$18M
Cash End of Period$34M$52M$27M$15M$33M
Free Cash Flow-$40M-$35M-$51M-$89M-$101M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms